4//SEC Filing
Waltermire Robert E. 4
Accession 0001628280-25-001900
CIK 0001157601other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 7:08 PM ET
Size
5.1 KB
Accession
0001628280-25-001900
Insider Transaction Report
Form 4
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
Transactions
- Sale
Common Stock
2025-01-17$273.41/sh−442$120,847→ 5,058 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001876996
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 7:08 PM ET
- Size
- 5.1 KB